ADIL - CIK 0001513525
The table below shows ADIAL PHARMACEUTICALS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $5.88M | $3.75M | $2.83M | $4.00M | $6.06M | $4.40M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $6.18M |
| $4.06M |
| $3.20M |
| $4.78M |
| $6.46M |
| $5.14M |
| Property, plant & equipment | - | - | - | $50.42K | $58.15K | - |
| Goodwill | - | - | - | $248.97K | $248.97K | - |
| Total assets | $6.67M | $5.04M | $4.74M | $5.73M | $7.47M | $5.49M |
| Accounts payable | $655.21K | $250.13K | $103.33K | $393.83K | $286.19K | $648.74K |
| Total current liabilities | $1.40M | $975.86K | $653.08K | $1.79M | $2.72M | $1.51M |
| Long-term debt | - | - | - | - | - | - |
| Total liabilities | $1.40M | $975.86K | $653.08K | $2.46M | $3.97M | - |
| Retained earnings | -$89.97M | -$82.00M | -$68.80M | -$63.67M | -$50.94M | -$31.52M |
| Total equity | $5.28M | $4.07M | $4.08M | $3.28M | $3.51M | $3.99M |